OCBCO
BLUE

Oversea-Chinese Banking Corp (OCBC)’s bluebird bio BLUE Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,223
Closed -$169K – 324
2022
Q4 		$169K Buy
+1,223
New +$172K 0.01% 334

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s BLUE Position: Q1 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of bluebird bio (BLUE) in Q1 2023, closing a stake of 1,223 shares — an estimated $169K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in BLUE in Q4 2022 and held it in 1 quarter. The position peaked at $169K in Q4 2022. 177 funds tracked by Wall St. Rank hold BLUE as of Q1 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining bluebird bio position as of Q1 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 1,223 bluebird bio shares in Q1 2023, an estimated $169K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in bluebird bio in Q4 2022 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s bluebird bio position peaked at $169K in Q4 2022.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q1 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2023, filed 4 May 2023.